We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VNO:NYSEVornado Realty Trust Analysis

Data as of 2026-08-31 - not real-time

$37.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $37.32, Vornado Realty Trust shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 6.1%. RSI sits at 41.5, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $37.28 and resistance around $41.60.
On valuation the read is fair — earnings multiple of 1244.0 versus a 31.9 sector average, above the peer group. The average analyst target implies 8.2% above today's level. Revenue is growing at 5.0% on a 3.6% profit margin. The 1.91% dividend yield looks stretched against payout coverage.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 29.6%, a beta of 1.01 and a maximum drawdown of 42.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

NEW YORK AP — NEW YORK AP — Vornado Realty Trust VNO on Monday reported a key measure of profitability in its...VNO heads into Q2 2026 earnings with revenues and FFO expected to rise higher as strong leasing and office demand...Shares of Vornado Realty Trust VNO have rallied 44.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 33.37
  • MACD momentum is negative
  • 30-day price change of -6.1%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 1244.0 versus sector average of 31.9
  • Dividend yield of 1.91% looks stretched against payout coverage
  • Trading above the 200-day average of 33.37

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 1244.0 versus sector average of 31.9
  • Dividend yield of 1.91% looks stretched against payout coverage
  • Analyst targets imply +8.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin3.62%
P/E Ratio1244.0
ROE0.60%
ROA1.01%
Debt/Equity122.32
Op. Cash Flow$390.9M
Free Cash Flow$445.7M
Industry P/E31.9

Technical Analysis

TrendNeutral
RSI41.5
Support$37.28
Resistance$41.60
MA 20$38.87
MA 50$39.14
MA 200$33.37
MACDBearish
VolumeDecreasing
Fear & Greed Index94.36

Valuation

Target Price$40.38
Upside/Downside8.21%
GradeFair
TypeBlend
Dividend Yield1.91%

Risk Assessment

Beta1.01
Volatility29.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.